Mezzasalma Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Sell
1,066
-25
-2% -$5.82K 0.07% 137
2025
Q4
$226K Sell
1,091
-106
-9% -$21K 0.05% 148
2025
Q3
$222K Buy
+1,197
New +$205K 0.06% 146
2025
Q2
Sell
-1,346
Closed -$223K 148
2025
Q1
$223K Buy
+1,346
New +$211K 0.08% 137
2024
Q2
Sell
-2,114
Closed -$334K 92
2024
Q1
$334K Sell
2,114
-381
-15% -$60.6K 0.16% 70
2023
Q4
$391K Sell
2,495
-63
-2% -$9.66K 0.21% 52
2023
Q3
$398K Sell
2,558
-1
-0% -$165 0.25% 51
2023
Q2
$424K Buy
2,559
+39
+2% +$6.29K 0.26% 53
2023
Q1
$391K Sell
2,520
-800
-24% -$129K 0.28% 52
2022
Q4
$586K Sell
3,320
-54
-2% -$9.32K 0.51% 37
2022
Q3
$551K Hold
3,374
0.44% 36
2022
Q2
$599K Buy
3,374
+831
+33% +$148K 0.51% 34
2022
Q1
$451K Buy
2,543
+1
+0% +$170 0.28% 45
2021
Q4
$435K Sell
2,542
-653
-20% -$107K 0.23% 55
2021
Q3
$516K Buy
3,195
+2
+0.1% +$341 0.29% 45
2021
Q2
$526K Sell
3,193
-326
-9% -$54K 0.29% 46
2021
Q1
$578K Sell
3,519
-120
-3% -$19.4K 0.37% 43
2020
Q4
$573K Buy
+3,639
New +$537K 0.37% 44

Other funds holding JNJ

Mezzasalma Advisors's JNJ Position: Q1 2026 in Review

Mezzasalma Advisors reduced its Johnson & Johnson (JNJ) stake by 2.3% in Q1 2026, selling an estimated $5.82K and leaving 1,066 shares worth $261K. The position accounts for 0.07% of the portfolio, ranked #137.

Mezzasalma Advisors first reported a position in JNJ in Q4 2020 and has held it in 18 quarters since. The position peaked at $599K in Q2 2022. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Mezzasalma Advisors held 1,066 shares of Johnson & Johnson worth $261K as of Q1 2026.
  • Mezzasalma Advisors sold 25 Johnson & Johnson shares in Q1 2026, an estimated $5.82K.
  • Johnson & Johnson made up 0.07% of Mezzasalma Advisors's portfolio in Q1 2026, its #137 holding.
  • Mezzasalma Advisors first reported a position in Johnson & Johnson in Q4 2020 and has held it in 18 quarters since.
  • Mezzasalma Advisors's Johnson & Johnson position peaked at $599K in Q2 2022.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Mezzasalma Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.